Related Experiment Video
Updated: Feb 27, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
High burden of coronary atherosclerosis in patients with cirrhosis
Konstantin Kazankov1, Kim Munk2, Kristian Altern Øvrehus3
1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Insights
Patients with cirrhosis have coronary artery disease (CAD) that is equally prevalent but more severe than in controls. Cirrhosis patients show higher plaque burden and more extensive CAD, indicating increased cardiovascular risk.
Area of Science:
- Cardiology
- Hepatology
- Vascular Biology
Background:
- Population studies indicate elevated cardiovascular mortality in cirrhosis patients.
- The frequency and extent of coronary artery disease (CAD) in general cirrhosis are not well understood.
- This study investigates CAD prevalence and severity in unselected cirrhosis patients.
Purpose of the Study:
- To assess the prevalence and extent of coronary artery disease (CAD) in patients with cirrhosis.
- To compare CAD characteristics between cirrhosis patients and a control group.
Main Methods:
- Coronary computed tomography angiography (CCTA) was used in 52 patients across all Child-Pugh classes and etiologies of cirrhosis.
- Patients had no known cardiac disease.
- Controls were individuals referred for new-onset chest pain.
Main Results:
- CAD prevalence was similar between cirrhosis patients (77%) and controls (65%).
- Cirrhosis patients exhibited significantly higher coronary artery calcification scores (120 vs. 5 HU) and total plaque volume (117 vs. 36 mm³).
- Patients with cirrhosis showed a higher prevalence of extensive CAD (45% vs. 18%) and multivessel disease (75% vs. 53%).
Conclusions:
- Coronary artery disease (CAD) has similar prevalence but is more extensive and severe in cirrhosis patients compared to controls.
- Cirrhosis patients present with high-risk CAD features linked to myocardial ischemia and adverse outcomes.
- Preventive strategies for CAD in cirrhosis warrant further investigation and attention.
Background:
Population studies report increased cardiovascular mortality in patients with cirrhosis. Coronary artery disease may be a trait of end-stage liver disease, but whether it is frequent or extensive in cirrhosis in general is unknown. Thus, we aimed to assess the prevalence and extent of coronary artery disease in unselected cirrhosis patients.
Materials And Methods:
Using coronary computed tomography angiography, we investigated 52 patients from all Child-Pugh classes and aetiologies of cirrhosis without known cardiac disease for presence and severity of coronary artery disease in a cross-sectional design. Persons referred with new-onset chest pain served as controls.
Results:
The prevalence of coronary artery disease was not significantly different between cirrhosis patients and controls (77% vs. 65%, P=0·19). However, cirrhosis patients had a markedly higher coronary artery calcification (Agatston) score than controls (120 [interquartile range, 0-345] vs. 5 [interquartile range, 0-86] HU, P=0·001). Likewise, patients with cirrhosis had a higher prevalence of extensive (≥5 coronary segments involved; 45% vs. 18%, P=0·01) and multivessel coronary disease (≥2 vessels involved; 75% vs. 53%, P=0·02). Furthermore, the total plaque volume whether noncalcified or calcified was higher in cirrhosis (117 [interquartile range, 0-310] vs. 36 [interquartile range, 0-148] mm3 , P=0·02).
Conclusion:
Coronary artery disease is equally prevalent in patients with cirrhosis and subjects with new-onset chest pain, but cirrhosis patients have more extensive and severe disease including several coronary high-risk features associated with myocardial ischaemia and a poor clinical outcome. The potential of preventive measures for coronary artery disease in cirrhosis needs attention.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease II: Pathophysiology
Atherosclerosis IV: Nursing Management
Atherosclerosis I: Introduction
